CTRI/2023/07/055556尚未招募4 期
Intranasal fentanyl as add-on therapy in screening of retinopathy of prematurity - A double blind randomized control trial. - NI
DR SANDIP KUMAR SAH0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Preterm infants heaving gestational age
- •<34 weeks or birth weight < 2000 gm were screened for retinopathy of prematurity
排除标准
- •Unstable neonates ( ventilate) and sedated neonate
- •Neonates with C/I for fentanyl
- •Neonates planned for surgery and neonate with congenital defects, and neurological disfunction
研究者
相似试验
已完成
4 期
The efficacy of intranasal fentanyl as an adjunct for pain management in retinopathy of prematurity screeningEfficacy of intranasal fentanyl drops as an adjunct for pain management in retinopathy of prematurity screening.Pain, retinopathy of prematurity, intranasal fentanylTCTR20230109003Bhumibol Adulyadej Hospital49
尚未招募
不适用
Efficacy of intranasal fentanyl for the treatment of moderate to severe pain in adult patients in the emergency departmentACTRN12613000652774Peninsula Health150
已完成
4 期
Intranasal Fentanyl as an Analgesic for Cystoscopic ProceduresPainNCT01708122Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center71
已完成
3 期
Efficacy and Safety of Intranasal Fentanyl in the Treatment of Breakthrough Pain (FT-018-IM)CancerNCT00362583Nycomed100
已完成
2 期
The Use of Intranasal Fentanyl for the Treatment of Incident Dyspnea in Congestive Heart Failure: A Prospective TrialDyspneaCongestive Heart FailureNCT02454751St. Boniface Hospital8